Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Developing vaccines is very hard work, as evidenced by Tuesday's news that AstraZeneca is pausing its clinical trials on a COVID-19 vaccine after a patient appeared to develop a serious neurological condition. And that raises an unsettling question: What if a vaccine is further away than most of us expect?

Axios Re:Cap digs in with Stat News reporter Adam Feuerstein, who helped break the AstraZeneca news.

Go deeper

Updated Dec 18, 2020 - Health

States say federal government cutting COVID-19 vaccine allocations

A sign announcing the beginning of immunizations against COVID-19 at the Pittsburgh VA Medical Center on in Pittsburgh, Pennsylvania. Photo: Jeff Swensen/Getty Images

Officials in several states have said the federal government told them to expect fewer doses of Pfizer's COVID-19 vaccine next week than originally anticipated.

The big picture: Some 2.9 million doses of the Pfizer-BioNTech vaccine were shipped this week as the U.S. started it's largest vaccination campaign in the nation's history. Health and Human Services Secretary Alex Azar said Wednesday that 2 million more doses of the Pfizer vaccine and 5.9 million doses of the Moderna vaccine could be allocated next week, per CNBC.

Updated 6 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Health: How data and the pandemic have democratized the "high-performance lifestyle — "Twindemic" averted as flu reports plummet amid coronavirus crisis
  2. Vaccine: Pfizer begins study on 3rd vaccine dose as booster shot against new strains — Republicans are least likely to want the coronavirus vaccine
  3. U.S. news: California surpasses 50,000 deaths COVID-19 deaths, more than any other state — Jimmy and Rosalynn Carter return to church after receiving COVID-19 vaccines
  4. Local: Public transit ridership in Twin Cities dropped 53% amid pandemic — Data firm predicts "complete chaos" in next phases of Florida's vaccine rolloutAlaska Gov. Mike Dunleavy tests positive for the coronavirus
Dec 17, 2020 - Health

CDC: Drug overdose deaths accelerated during pandemic

Illustration: Sarah Grillo/Axios

An estimated 81,000 people died from a drug overdose between June 2019 and May 2020, the highest number ever recorded in a 12-month period, according to a Centers for Disease Control and Prevention report released on Thursday.

Why it matters: The provisional data suggests the pandemic accelerated overdose deaths.